|
|
Volumn 31, Issue 3, 2010, Pages 263-265
|
|
Clinical trials sessions from the American Heart Association Annual Meeting, Florida 2009
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ADENOSINE DIPHOSPHATE RECEPTOR ANTAGONIST;
CLOPIDOGREL;
EZETIMIBE;
HYDROLASE INHIBITOR;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
IRON;
NICOTINIC ACID;
PLACEBO;
SODIUM CHLORIDE;
TICAGRELOR;
UNCLASSIFIED DRUG;
ACUTE CORONARY SYNDROME;
ANEMIA;
ARTERIAL WALL THICKNESS;
ARTIFICIAL HEART PACEMAKER;
ATHEROSCLEROSIS;
CARDIAC RESYNCHRONIZATION THERAPY;
CARDIOMEGALY;
CARDIOVASCULAR DISEASE;
CAROTID ARTERY;
CHOLESTEROL BLOOD LEVEL;
CLINICAL ASSESSMENT;
CLINICAL TRIAL;
CONFERENCE PAPER;
DRUG BINDING;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG RELEASE;
DRUG SAFETY;
DYSPNEA;
EXERCISE;
HEALTH SURVEY;
HEART DEATH;
HEART FAILURE;
HEART INFARCTION;
HOSPITAL;
HOSPITALIZATION;
HUMAN;
HYPERCHOLESTEROLEMIA;
IRON BLOOD LEVEL;
LABORATORY TEST;
MEDICAL SOCIETY;
MORTALITY;
PERCUTANEOUS CORONARY INTERVENTION;
PRIORITY JOURNAL;
QUALITY OF LIFE;
RISK REDUCTION;
ST SEGMENT ELEVATION;
STENT THROMBOSIS;
SURVIVAL RATE;
SYMPTOM;
TREATMENT OUTCOME;
UNITED STATES;
|
|
EID: 76349110090
PISSN: 0195668X
EISSN: 15229645
Source Type: Journal
DOI: 10.1093/eurheartj/ehp544 Document Type: Conference Paper |
|
Times cited : (3)
|
|
References (1)
|
